Applied DNA Clinical Labs (ADCL), a subsidiary of Applied DNA Sciences, provides molecular and genomic testing services enabled by our expertise in DNA-based sciences and technologies. We serve businesses, healthcare providers, researchers and patients directly and through reliable and innovative clinical and reference laboratory services.
Pharmacogenomics – TR8™ PGx
ADCL provides advanced pharmacogenomics services to optimize patient care through precision prescribing, enabling healthcare providers to personalize treatments based on genetic makeup for safer, more effective outcomes across multiple therapeutic areas.
Applied DNA Clinical Labs, LLC (“ADCL”) is a NYSDOH CLEP-permitted, Clinical Laboratory Improvement Amendments (“CLIA”)-certified clinical laboratory certified to perform high-complexity testing. The TR8 test was developed, and its performance characteristics were determined by ADCL. The TR8 test has not been cleared or approved by the U.S. Food and Drug Administration. The TR8 test is intended for clinical purposes and is available via prescription only.
COVID-19 Testing Services
With nearly one million tests performed, ADCL played a vital role in COVID-19 response, providing high-accuracy PCR testing for various sectors. Our ongoing services support safety, productivity, and continuity through comprehensive testing and result reporting.
Mpox Testing Solutions
Leveraging PCR-based DNA technologies, ADCL offers Mpox testing for Clade I and II MPXV as a specialized reference lab.
